ACM
CLVS

Advent Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Advent Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,000
Closed -$147K – 348
2018
Q3 		$147K Buy
+5,000
New +$194K ﹤0.01% 225
2017
Q4 		– Sell
-5,000
Closed -$412K – 323
2017
Q3 		$412K Sell
5,000
-13,750
-73% -$1.09M 0.01% 206
2017
Q2 		$1.76M Buy
18,750
+13,750
+275% +$841K 0.03% 171
2017
Q1 		$318K Buy
+5,000
New +$304K 0.01% 201
2016
Q4 		– Sell
-5,000
Closed -$176K – 346
2016
Q3 		$180K Buy
+5,000
New +$107K ﹤0.01% 418
2016
Q2 		– Sell
-13,900
Closed -$267K – 494
2016
Q1 		$267K Buy
+13,900
New +$294K ﹤0.01% 349

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return